의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4609 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 7.40 USD | +8.98% | -16.76% | -29.66% | +26.50% | 11.98 M USD | ||
| 4610 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.24 USD | +4.35% | -22.58% | -4.00% | -76.92% | 11.97 M USD | ||
| 4614 |  SINT SiNtx Technologies, Inc. - Common Stock | 1.77 USD | -2.75% | -16.51% | +4.73% | -42.90% | 11.80 M USD | ||
| 4615 |  INAB IN8bio, Inc. - Common Stock | 1.19 USD | -0.83% | -12.50% | +15.53% | -28.74% | 11.73 M USD | ||
| 4617 |  PLUR Pluri Inc. - Common Stock | 0.94 USD | +1.08% | -3.09% | -11.32% | -75.39% | 11.60 M USD | ||
| 4619 |  PASG Passage Bio, Inc. - Common Stock | 3.60 USD | -1.64% | -6.01% | -27.71% | -59.28% | 11.58 M USD | ||
| 4621 |  PTN Palatin Technologies, Inc. Common Stock | 6.49 USD | -15.27% | -29.46% | -31.76% | -10.48% | 11.56 M USD | ||
| 4626 |  DARE Dare Bioscience, Inc. - Common Stock | 0.74 USD | +1.37% | -6.33% | 0.00% | -55.15% | 11.31 M USD | ||
| 4627 |  ENSC Ensysce Biosciences, Inc. - Common Stock | 0.58 USD | +3.57% | +20.83% | +28.89% | +52.63% | 11.28 M USD | ||
| 4629 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 1.19 USD | +0.85% | -15.60% | -50.42% | -62.10% | 11.25 M USD | ||
| 4631 |  INTS Intensity Therapeutics, Inc. - Common Stock | 3.42 USD | 0.00% | -8.80% | -14.29% | +1215.38% | 11.17 M USD | ||
| 4637 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 0.93 USD | -2.11% | -4.12% | -9.71% | -21.85% | 10.80 M USD | ||
| 4639 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.41 USD | -2.03% | -4.37% | -9.06% | +14.76% | 10.66 M USD | ||
| 4647 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.87 USD | +1.16% | -7.45% | +2.35% | -61.67% | 10.29 M USD | ||
| 4651 |  TOVX Theriva Biologics, Inc. Common Stock | 0.22 USD | +4.76% | -4.35% | -4.35% | -12.00% | 10.10 M USD | ||
| 4660 |  BFRG Bullfrog AI Holdings, Inc. - Common Stock | 0.53 USD | -1.85% | -22.06% | +23.26% | -63.95% | 9.83 M USD | ||
| 4665 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.07 USD | +4.90% | -16.41% | -57.20% | -55.97% | 9.64 M USD | ||
| 4666 |  CTSO Cytosorbents Corporation - Common Stock | 3.06 USD | -0.97% | -16.62% | -48.66% | +236.26% | 9.61 M USD | ||
| 4672 |  TPST Tempest Therapeutics, Inc. - Common Stock | 0.64 USD | 0.00% | -20.99% | -40.74% | -73.22% | 9.48 M USD | ||
| 4673 |  NMTC NeuroOne Medical Technologies Corporation - Common Stock | 1.04 USD | -1.89% | -2.80% | -29.73% | +22.35% | 9.47 M USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |